Naringenin prevents cholesterol-induced systemic infl ammation, metabolic dysregulation, and atherosclerosis in Ldlr/mice

Journal of Lipid Research

Volumn 54, Issue 3, 2013, Pages 711-724

  Assini, Julia M ^a,b   Mulvihill, Erin E ^a,b   Sutherland, Brian G ^a   Telford, Dawn E ^a,b   Sawyez, Cynthia G ^a,b   Felder, Sarah L ^a,b   Chhoker, Sanjiv ^a,b   Edwards, Jane Y ^a,b   Gros, Robert ^a,b,c   Huff, Murray W ^a,b  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b Department of Medicine ^*  (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Cholesterol; Fl avonoid; Hepatic steatosis; Insulin resistance; Lipids; Metabolism; Obesity

Indexed keywords

CHOLESTEROL; FATTY ACID; NARINGENIN; VERY LOW DENSITY LIPOPROTEIN;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; AORTA ATHEROSCLEROSIS; AORTITIS; ARTICLE; ATHEROSCLEROSIS; CELL INFILTRATION; CHOLESTEROL INTAKE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FATTY ACID METABOLISM; FATTY ACID SYNTHESIS; FATTY LIVER; FOAM CELL; HYPERLIPIDEMIA; INFLAMMATION; INSULIN RESISTANCE; LIPOPROTEIN SYNTHESIS; LIVER METABOLISM; MACROPHAGE MIGRATION; MALE; METABOLIC DISORDER; MOUSE; MOUSE STRAIN; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; SYSTEMIC DISEASE; SYSTEMIC INFLAMMATION; TISSUE EXPANSION; TREATMENT DURATION;

ANIMALS; ATHEROSCLEROSIS; CHOLESTEROL; FATTY LIVER; FLAVANONES; FLAVONOIDS; INFLAMMATION; INSULIN RESISTANCE; MALE; MICE; MICE, KNOCKOUT; RECEPTORS, LDL;

EID: 84874025229     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M032631     Document Type: Article

References (55)

1. Subramanian, S., and A. Chait. 2009. The effect of dietary cholesterol on macrophage accumulation in adipose tissue: implications for systemic infl ammation and atherosclerosis. Curr. Opin. Lipidol. 20 : 39-44.
2. Gustafson, B., A. Hammarstedt, C. X. Andersson, and U. Smith. 2007. Infl amed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 27 : 2276-2283.
3. Gutierrez, D. A., M. J. Puglisi, and A. H. Hasty. 2009. Impact of increased adipose tissue mass on infl ammation, insulin resistance, and dyslipidemia. Curr. Diab. Rep. 9 : 26-32.
4. Merat, S., F. Casanada, M. Sutphin, W. Palinski, and P. D. Reaven. 1999. Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-defi cient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet. Arterioscler. Thromb. Vasc. Biol. 19 : 1223-1230.
5. Mulvihill, E. E., E. M. Allister, B. G. Sutherland, D. E. Telford, C. G. Sawyez, J. Y. Edwards, J. M. Markle, R. A. Hegele, and M. W. Huff. 2009. Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance. Diabetes. 58 : 2198-2210.
6. Subramanian, S., C. Y. Han, T. Chiba, T. S. McMillen, S. A. Wang, A. Haw 3rd, E. A. Kirk, K. D. O'Brien, and A. Chait. 2008. Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-defi cient mice. Arterioscler. Thromb. Vasc. Biol. 28 : 685-691.
7. Subramanian, S., L. Goodspeed, S. A. Wang, J. Kim, L. Zeng, G. N. Ioannou, W. G. Haigh, M. M. Yeh, K. V. Kowdley, K. D. O'Brien, et al. 2011. Dietary cholesterol exacerbates hepatic steatosis and infl ammation in obese LDL receptor-defi cient mice. J. Lipid Res. 52 : 1626-1635.
8. Lewis, K. E., E. A. Kirk, T. O. McDonald, S. Wang, T. N. Wight, K. D. O'Brien, and A. Chait. 2004. Increase in serum amyloid a evoked by dietary cholesterol is associated with increased atherosclerosis in mice. Circulation. 110 : 540-545.
9. Basciano, H., A. E. Miller, M. Naples, C. Baker, R. Kohen, E. Xu, Q. Su, E. M. Allister, M. B. Wheeler, and K. Adeli. 2009. Metabolic effects of dietary cholesterol in an animal model of insulin resistance and hepatic steatosis. Am. J. Physiol. Endocrinol. Metab. 297 : E462-E473.
10. Qin, B., R. A. Anderson, and K. Adeli. 2008. Tumor necrosis factor-alpha directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling. Am. J. Physiol. Gastrointest. Liver Physiol. 294 : G1120-G1129.
11. Bartolomé, N., B. Arteta, M. J. Martinez, Y. Chico, and B. Ochoa. 2008. Kupffer cell products and interleukin 1beta directly promote VLDL secretion and apoB mRNA up-regulation in rodent hepatocytes. Innate Immun. 14 : 255-266.
12. Mulvihill, E. E., and M. W. Huff. 2010. Antiatherogenic properties of fl avonoids: implications for cardiovascular health. Can. J. Cardiol. 26(Suppl A): 17A-21A.
13. González, R., I. Ballester, R. Lopez-Posadas, M. D. Suarez, A. Zarzuelo, O. Martinez-Augustin, and F. Sanchez de Medina. 2011. Effects of fl avonoids and other polyphenols on infl ammation. Crit. Rev. Food Sci. Nutr. 51 : 331-362.
14. Borradaile, N. M., L. E. de Dreu, and M. W. Huff. 2003. Inhibition of net HepG2 cell apolipoprotein B secretion by the citrus fl avonoid naringenin involves activation of phosphatidylinositol 3-kinase, independent of insulin receptor substrate-1 phosphorylation. Diabetes. 52 : 2554-2561.
15. Mulvihill, E. E., J. M. Assini, B. G. Sutherland, A. S. DiMattia, M. Khami, J. B. Koppes, C. G. Sawyez, S. C. Whitman, and M. W. Huff. 2010. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice. Arterioscler. Thromb. Vasc. Biol. 30 : 742-748.
16. Teupser, D., A. D. Persky, and J. L. Breslow. 2003. Induction of atherosclerosis by low-fat semi-synthetic diets in low density lipoprotein defi cient C57BL/6J and FVB/NJ mice: comparison of lesions of the aortic root, brachiocephalic artery and whole aorta (en face measurement). Arterioscler. Thromb. Vasc. Biol. 23 : 1907-1913.
17. Mulvihill, E. E., J. M. Assini, J. K. Lee, E. M. Allister, B. G. Sutherland, J. B. Koppes, C. G. Sawyez, J. Y. Edwards, D. E. TelfordA. Charbonneau, et al. 2011. Nobiletin attenuates VLDL overproduction, dyslipidemia, and atherosclerosis in mice with dietinduced insulin resistance. Diabetes. 60 : 1446-1457.
18. Huff, M. W., D. E. Telford, J. Y. Edwards, J. R. Burnett, P. H. Barrett, S. R. Rapp, N. Napawan, and B. T. Keller. 2002. Inhibition of the apical sodium-dependent bile acid transporter reduces LDL cholesterol and apoB by enhanced plasma clearance of LDL apoB. Arterioscler. Thromb. Vasc. Biol. 22 : 1884-1891.
19. Folch, J., M. Lees, and G. H. Sloane Stanley. 1957. A simple method for the isolation and purifi cation of total lipides from animal tissues. J. Biol. Chem. 226 : 497-509.
20. Burnett, J. R., L. J. Wilcox, D. E. Telford, S. J. Kleinstiver, P. H. Barrett, R. S. Newton, and M. W. Huff. 1997. Inhibition of HMGCoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs. Arterioscler. Thromb. Vasc. Biol. 17 : 2589-2600.
21. Granton, P. V., C. J. Norley, J. Umoh, E. A. Turley, B. C. Frier, E. G. Noble, and D. W. Holdsworth. 2010. Rapid in vivo whole body composition of rats using cone beam muCT. J. Appl. Physiol. 109 : 1162-1169.
22. Li, A. C., C. J. Binder, A. Gutierrez, K. K. Brown, C. R. Plotkin, J. W. Pattison, A. F. Valledor, R. A. Davis, T. M. Willson, J. L. Witztum, et al. 2004. Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma. J. Clin. Invest. 114 : 1564-1576.
23. Wilcox, L. J., P. H. Barrett, R. S. Newton, and M. W. Huff. 1999. ApoB100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011: an effect associated with enhanced intracellular degradation of ApoB. Arterioscler. Thromb. Vasc. Biol. 19 : 939-949.
24. Wouters, K., P. J. van Gorp, V. Bieghs, M. J. Gijbels, H. Duimel, D. Lutjohann, A. Kerksiek, R. van Kruchten, N. Maeda, B. Staels, et al. 2008. Dietary cholesterol, rather than liver steatosis, leads to hepatic infl ammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology. 48 : 474-486.
25. Surmi, B. K., and A. H. Hasty. 2008. Macrophage infi ltration into adipose tissue: initiation, propagation and remodeling. Future Lipidol. 3 : 545-556.
26. Sniderman, A. D., T. Pedersen, and J. Kjekshus. 1997. Putting lowdensity lipoproteins at center stage in atherogenesis. Am. J. Cardiol. 79 : 64-67.
27. Roncal-Jimenez, C. A., M. A. Lanaspa, C. J. Rivard, T. Nakagawa, L. G. Sanchez-Lozada, D. Jalal, A. Andres-Hernando, K. Tanabe, M. Madero, N. Li, et al. 2011. Sucrose induces fatty liver and pancreatic infl ammation in male breeder rats independent of excess energy intake. Metabolism. 60 : 1259-1270.
28. Repa, J. J., G. Liang, J. Ou, Y. Bashmakov, J. M. Lobaccaro, I. Shimomura, B. Shan, M. S. Brown, J. L. Goldstein, and D. J. Mangelsdorf. 2000. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev. 14 : 2819-2830.
29. Adiels, M., S. O. Olofsson, M. R. Taskinen, and J. Boren. 2008. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 28 : 1225-1236.
30. Adiels, M., M. R. Taskinen, C. Packard, M. J. Caslake, A. Soro-Paavonen, J. Westerbacka, S. Vehkavaara, A. Hakkinen, S. O. Olofsson, H. Yki-Jarvinen, et al. 2006. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia. 49 : 755-765.
31. Abu-Elheiga, L., M. M. Matzuk, K. A. Abo-Hashema, and S. J. Wakil. 2001. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science. 291 : 2613-2616.
32. Abu-Elheiga, L., W. Oh, P. Kordari, and S. J. Wakil. 2003. Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets. Proc. Natl. Acad. Sci. USA. 100 : 10207-10212.
33. Abu-Elheiga, L., H. Wu, Z. Gu, R. Bressler, and S. J. Wakil. 2012. Acetyl-CoA carboxylase 2-/-mutant mice are protected against fatty liver under high-fat, high-carbohydrate dietary and de novo lipogenic conditions. J. Biol. Chem. 287 : 12578-12588.
34. Choi, C. S., D. B. Savage, L. Abu-Elheiga, Z. X. Liu, S. Kim, A. Kulkarni, A. Distefano, Y. J. Hwang, R. M. Reznick, R. Codella, et al. 2007. Continuous fat oxidation in acetyl-CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity. Proc. Natl. Acad. Sci. USA. 104 : 16480-16485.
35. Hoehn, K. L., N. Turner, M. M. Swarbrick, D. Wilks, E. Preston, Y. Phua, H. Joshi, S. M. Furler, M. Larance, B. D. Hegarty, et al. 2010. Acute or chronic upregulation of mitochondrial fatty acid oxidation has no net effect on whole-body energy expenditure or adiposity. Cell Metab. 11 : 70-76.
36. Stefanovic-Racic, M., G. Perdomo, B. S. Mantell, I. J. Sipula, N. F. Brown, and R. M. O'Doherty. 2008. A moderate increase in carnitine palmitoyltransferase 1a activity is suffi cient to substantially reduce hepatic triglyceride levels. Am. J. Physiol. Endocrinol. Metab. 294 : E969-E977.
37. Orellana-Gavaldà, J. M., L. Herrero, M. I. Malandrino, A. Paneda, M. Sol Rodriguez-Pena, H. Petry, G. Asins, S. Van Deventer, F. G. Hegardt, and D. Serra. 2011. Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation. Hepatology. 53 : 821-832.
38. Randle, P. J., P. B. Garland, E. A. Newsholme, and C. N. Hales. 1965. The glucose fatty acid cycle in obesity and maturity onset diabetes mellitus. Ann. N. Y. Acad. Sci. 131 : 324-333.
39. Huang, W., A. Metlakunta, N. Dedousis, P. Zhang, I. Sipula, J. J. Dube, D. K. Scott, and R. M. O'Doherty. 2010. Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance. Diabetes. 59 : 347-357.
40. Marí, M., F. Caballero, A. Colell, A. Morales, J. Caballeria, A. Fernandez, C. Enrich, J. C. Fernandez-Checa, and C. Garcia-Ruiz. 2006. Mitochondrial free cholesterol loading sensitizes to TNF-and Fas-mediated steatohepatitis. Cell Metab. 4 : 185-198.
41. Li, Y., R. F. Schwabe, T. DeVries-Seimon, P. M. Yao, M. C. Gerbod-Giannone, A. R. Tall, R. J. Davis, R. Flavell, D. A. Brenner, and I. Tabas. 2005. Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-alpha and interleukin-6: model of NF-kappaB-and map kinase-dependent infl ammation in advanced atherosclerosis. J. Biol. Chem. 280 : 21763-21772.
42. Suganami, T., K. Tanimoto-Koyama, J. Nishida, M. Itoh, X. Yuan, S. Mizuarai, H. Kotani, S. Yamaoka, K. Miyake, S. Aoe, et al. 2007. Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced infl ammatory changes in the interaction between adipocytes and macrophages. Arterioscler. Thromb. Vasc. Biol. 27 : 84-91.
43. Anderson, E. K., A. A. Hill, and A. H. Hasty. 2012. Stearic acid accumulation in macrophages induces toll-like receptor 4/2-independent infl ammation leading to endoplasmic reticulum stress-mediated apoptosis. Arterioscler. Thromb. Vasc. Biol. 32 : 1687-1695.
44. Xu, H., G. T. Barnes, Q. Yang, G. Tan, D. Yang, C. J. Chou, J. Sole, A. Nichols, J. S. Ross, L. A. Tartaglia, et al. 2003. Chronic infl ammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112 : 1821-1830.
45. Weisberg, S. P., D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and A. W. Ferrante, Jr. 2003. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112 : 1796-1808.
46. Coenen, K. R., M. L. Gruen, A. Chait, and A. H. Hasty. 2007. Dietinduced increases in adiposity, but not plasma lipids, promote macrophage infi ltration into white adipose tissue. Diabetes. 56 : 564-573.
47. Galic, S., M. D. Fullerton, J. D. Schertzer, S. Sikkema, K. Marcinko, C. R. Walkley, D. Izon, J. Honeyman, Z. P. Chen, B. J. van Denderen, et al. 2011. Hematopoietic AMPK beta1 reduces mouse adipose tissue macrophage infl ammation and insulin resistance in obesity. J. Clin. Invest. 121 : 4903-4915.
48. Yang, J., Q. Li, X. D. Zhou, V. P. Kolosov, and J. M. Perelman. 2011. Naringenin attenuates mucous hypersecretion by modulating reactive oxygen species production and inhibiting NF-kappaB activity via EGFR-PI3K-Akt/ERK MAPKinase signaling in human airway epithelial cells. Mol. Cell. Biochem. 351 : 29-40.
49. Hotamisligil, G. S., P. Peraldi, A. Budavari, R. Ellis, M. F. White, and B. M. Spiegelman. 1996. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha-and obesity-induced insulin resistance. Science. 271 : 665-668.
50. Hotamisligil, G. S., D. L. Murray, L. N. Choy, and B. M. Spiegelman. 1994. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc. Natl. Acad. Sci. USA. 91 : 4854-4858.
51. Chuang, C. C., K. Martinez, G. Xie, A. Kennedy, A. Bumrungpert, A. Overman, W. Jia, and M. K. McIntosh. 2010. Quercetin is equally or more effective than resveratrol in attenuating tumor necrosis factor-{alpha}-mediated infl ammation and insulin resistance in primary human adipocytes. Am. J. Clin. Nutr. 92 : 1511-1521.
52. Berg, A. H., and P. E. Scherer. 2005. Adipose tissue, infl ammation, and cardiovascular disease. Circ. Res. 96 : 939-949.
53. Whitman, S. C. 2004. A practical approach to using mice in atherosclerosis research. Clin. Biochem. Rev. 25 : 81-93.
54. Tabas, I. 2010. Macrophage death and defective infl ammation resolution in atherosclerosis. Nat. Rev. Immunol. 10 : 36-46.
55. Bodet, C., V. D. La, F. Epifano, and D. Grenier. 2008. Naringenin has anti-infl ammatory properties in macrophage and ex vivo human whole-blood models. J. Periodontal Res. 43 : 400-407.